You are on page 1of 1

Primary hemostatic plug 역할

α-granule Fibrinogen Aggregation (cross-linking), Afibrinogenemia Secretion


GP 2b/3a (Rc 결핍 : Glanzmann's thrombasthenia) Aggregation
Clot retraction
vWF GP 1b/9/10 (Rc 결핍 : Bernard-Soulier)
Adhesion
Component
vWF disease
Factor 5
- Secreton defect(경증) 시 민감x)

Dense granule Ca+ Acquired platelet secretion defect (aspirin) : COX 차단


(PFA-100 : Closure time 확인

Secretion
ADP Weak activator, Recruitment of more plt
P2Y1, P2Y12 (Ticlopidine, clopidogrel Rx)
Secretion
Plt secretion defect (Storage pool d/s)
Platelet

Strong Collagen GP 1a/2a/6, subendo Adhesion


Thrombin (Coagulation에서 thrombomodulin과 결합, PC활성화)
Activator

Weak Thromboxane A2 Secreted, Recruitment of more plt,


Prostagladin H2 Plt secretion defect (Storage pool d/s)
Secretion
Acquired platelet secretion defect (aspirin)

Epi

Inhibitors CD39 (ADPase)


NO
PGI2

Secondary hemostatic plug


Activation 시 Plt mbr 안 --> 밖 translocation
Phosphatidyl serine Providing surface for pro-coagulant complex
응고장소 (Plt 표면) 제공
Scott's s/d (defective translocation)

12 결핍되도 no problemo

Vit K-dep : 2, 7, 9, 10
11
Intrinsic

8 vWF 결핍 -> F8 stabilisation defect

Tenase (9a-8a-Ca) 10 활성화


(혈우병 : 감소 -> 출혈)
Coagulation factor

항상 발현 중 : fibroblast, smooth mm.


Tissue Factor (3) Inducible : endo (혈관 손상), monocyte, microparticle Coagulation initiator
Extrinsic
7 10, 9 활성화

10
5 5a의 R506Q 경우 APC 저항성 생김 (F5 Leiden)
Common

Prothrombinase (10a-5a-Ca)
Prothrombin (2)
Fibrinogen (1)
Fibrin 형성 후 cross-linkage를 통해 clot을 견고하게.
13
Ptn C 활성화된 APC + PS -> F5a, 8a 비활성화
Ptn C def : thromobophilia
Natural Anticoagulant

Ptn S APC와 결합 -> F5a, 8a 비활성화


Ptn C system

Thrombomodulin Thrombin와 결합 -> APC (활성화된 PC) Anti-coagulation


(항응고)
Blood thining.
Antithrombin Thrombin과 F10 억제; activated by heparin

Tissue Factor Pathway Inh (TFPI) Extrinsinc과 F10 억제

tPA, uPA Inactive한 plasminogen이 plasmin으로 활성화


Plasminogen activator 간질환, 전립선암에서 증가 -> 출혈
Fibrin clot 제거
Plasmin Fibrin clot 용해 -> FDP + D-dimer (섬유소 용해)
Fibrolytic factors

α2-antiplasmin Free plasmin과 결합해, 과도한 fibrinolysis를 차단

PAI-1 > 2 Plasminogen activator (tPA > uPA)와 결합해 작용억제


Inactivator

TAFI Fibrin 구조를 바꿔 plasmin이 작용 못 함

You might also like